PALO
Palo Protocol
Triple Stack — SLU-PP-332 + 5-Amino-1MQ + BPC-157 — Palo Protocol — coming soon

Palo Protocol

Triple Stack — SLU-PP-332 + 5-Amino-1MQ + BPC-157

Metabolic

250 mcg / 25 mg / 125 mcg · 90 capsules

Three preclinical compounds in one capsule. No one has studied this combination, including us. We are listing it for transparency about what our partner manufactures, not as a recommendation.

Not available for purchase

What we know

Mechanism
Combines ERR-alpha agonism, NNMT inhibition and BPC-157 at reduced individual doses in a 90-count format.
Evidence state
No study has evaluated this combination. Each component is individually preclinical.
Regulatory note
Contains BPC-157, on the FDA 503A Category 2 list. Prescriber pathway only.

Disclaimer

This product is not available for purchase. It has not been evaluated by the FDA and is not intended to diagnose, treat, cure or prevent any disease. Nothing on this page is medical advice. Palo lists this compound for transparency about our supply partnerships; any future availability would run through a licensed prescriber and a compounding pharmacy, not through this website.